Literature DB >> 26773515

Effects of a ketogenic diet on ADHD-like behavior in dogs with idiopathic epilepsy.

Rowena M A Packer1, Tsz Hong Law2, Emma Davies3, Brian Zanghi4, Yuanlong Pan4, Holger A Volk3.   

Abstract

OBJECTIVES: Epilepsy in humans and rodent models of epilepsy can be associated with behavioral comorbidities including an increased prevalence of attention-deficit/hyperactivity disorder (ADHD). Attention-deficit/hyperactivity disorder symptoms and seizure frequency have been successfully reduced in humans and rodents using a ketogenic diet (KD). The aims of this study were (i) to describe the behavioral profile of dogs with idiopathic epilepsy (IE) while on a standardized nonketogenic placebo diet, to determine whether ADHD-like behaviors are present, and (ii) to examine the effect of a ketogenic medium chain triglyceride diet (MCTD) on the behavioral profile of dogs with idiopathic epilepsy (IE) compared with the standardized placebo control diet, including ADHD-like behaviors.
METHODS: A 6-month prospective, randomized, double-blinded, placebo-controlled, crossover dietary trial comparing the effects of the MCTD with a standardized placebo diet on canine behavior was carried out. Dogs diagnosed with IE, with a seizure frequency of at least 3 seizures in the past 3months (n=21), were fed the MCTD or placebo diet for 3months and were then switched to the alternative diet for 3months. Owners completed a validated behavioral questionnaire to measure 11 defined behavioral factors at the end of each diet period to report their dogs' behavior, with three specific behaviors hypothesized to be related to ADHD: excitability, chasing, and trainability.
RESULTS: The highest scoring behavioral factors in the placebo and MCTD periods were excitability (mean±SE: 1.910±0.127) and chasing (mean±SE: 1.824±0.210). A markedly lower trainability score (mean±SE: 0.437±0.125) than that of previously studied canine populations was observed. The MCTD resulted in a significant improvement in the ADHD-related behavioral factor chasing and a reduction in stranger-directed fear (p<0.05) compared with the placebo diet. The latter effect may be attributed to previously described anxiolytic effects of a KD.
CONCLUSIONS: These data support the supposition that dogs with IE may exhibit behaviors that resemble ADHD symptoms seen in humans and rodent models of epilepsy and that a MCTD may be able to improve some of these behaviors, along with potentially anxiolytic effects.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anxiolytic; Attention-deficit/hyperactivity disorder; Canine; Comorbidity; Ketogenic; Medium chain triglyceride diet

Mesh:

Substances:

Year:  2016        PMID: 26773515     DOI: 10.1016/j.yebeh.2015.11.014

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  18 in total

1.  Once-daily feeding is associated with better health in companion dogs: results from the Dog Aging Project.

Authors:  Emily E Bray; Zihan Zheng; M Katherine Tolbert; Brianah M McCoy; Matt Kaeberlein; Kathleen F Kerr
Journal:  Geroscience       Date:  2022-04-28       Impact factor: 7.581

2.  Investigating the potential of the anti-epileptic drug imepitoin as a treatment for co-morbid anxiety in dogs with idiopathic epilepsy.

Authors:  Rowena M A Packer; Luisa De Risio; Holger A Volk
Journal:  BMC Vet Res       Date:  2017-04-07       Impact factor: 2.741

Review 3.  The Current Status of the Ketogenic Diet in Psychiatry.

Authors:  Emmanuelle C S Bostock; Kenneth C Kirkby; Bruce V M Taylor
Journal:  Front Psychiatry       Date:  2017-03-20       Impact factor: 4.157

4.  Cognitive dysfunction in naturally occurring canine idiopathic epilepsy.

Authors:  Rowena M A Packer; Paul D McGreevy; Hannah E Salvin; Michael J Valenzuela; Chloe M Chaplin; Holger A Volk
Journal:  PLoS One       Date:  2018-02-08       Impact factor: 3.240

5.  A double-blinded randomised dietary supplement crossover trial design to investigate the short-term influence of medium chain fatty acid (MCT) supplement on canine idiopathic epilepsy: study protocol.

Authors:  Benjamin Andreas Berk; Rowena Mary Anne Packer; Tsz Hong Law; Annette Wessmann; Andrea Bathen-Nöthen; Tarja Susanna Jokinen; Anna Knebel; Andrea Tipold; Ludovic Pelligand; Holger Andreas Volk
Journal:  BMC Vet Res       Date:  2019-05-30       Impact factor: 2.741

Review 6.  Therapeutic Potential of Exogenous Ketone Supplement Induced Ketosis in the Treatment of Psychiatric Disorders: Review of Current Literature.

Authors:  Zsolt Kovács; Dominic P D'Agostino; David Diamond; Mark S Kindy; Christopher Rogers; Csilla Ari
Journal:  Front Psychiatry       Date:  2019-05-23       Impact factor: 4.157

7.  Metabolic perturbations associated with the consumption of a ketogenic medium-chain TAG diet in dogs with idiopathic epilepsy.

Authors:  Tsz Hong Law; Holger A Volk; Yuanlong Pan; Brian Zanghi; Elizabeth J Want
Journal:  Br J Nutr       Date:  2018-07-13       Impact factor: 3.718

8.  Behavioral Changes in Dogs With Idiopathic Epilepsy Compared to Other Medical Populations.

Authors:  Hilary Levitin; Devon Wallis Hague; Kelly C Ballantyne; Laura E Selmic
Journal:  Front Vet Sci       Date:  2019-11-08

9.  A multicenter randomized controlled trial of medium-chain triglyceride dietary supplementation on epilepsy in dogs.

Authors:  Benjamin A Berk; Tsz H Law; Rowena M A Packer; Annette Wessmann; Andrea Bathen-Nöthen; Tarja S Jokinen; Anna Knebel; Andrea Tipold; Ludovic Pelligand; Zoe Meads; Holger A Volk
Journal:  J Vet Intern Med       Date:  2020-04-15       Impact factor: 3.333

10.  Behavioural Differences in Dogs with Atopic Dermatitis Suggest Stress Could Be a Significant Problem Associated with Chronic Pruritus.

Authors:  Naomi D Harvey; Peter J Craigon; Stephen C Shaw; Sarah C Blott; Gary C W England
Journal:  Animals (Basel)       Date:  2019-10-16       Impact factor: 2.752

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.